| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |